Search results for "Hepatitis"

Results 1 - 10 of about 46 for "Hepatitis".

Review: In chronic hepatitis C virus infection, oral direct-acting antivirals have high sustained virologic response | ACP Gastroenterology Monthly

A commentary in ACP Journal Club noted that while screening and treating all patients with chronic hepatitis C virus (HCV) would be cost-effective and probably cost-saving, some payers are still resistant.

ACP and the American Academy of HIV Medicine collaborate on new guide to hepatitis C testing | ACP Gastroenterology Monthly

The guide includes a summary of the latest testing recommendations; diagnostic, billing, and laboratory codes for testing; resources for referrals to HCV-experienced clinicians; and information on patient interactions, education, conversations, and

ACIP revises recommendations on hepatitis A vaccination | ACP Gastroenterology Monthly

For postexposure prophylaxis, the hepatitis A vaccine is now preferred to immune globulin for all adults, including those older than 40 years of age, the Advisory Committee on Immunization Practices (ACIP) said.

Spotlight on hepatitis B vaccination | ACP Gastroenterology Monthly

The Advisory Committee on Immunization Practices released new recommendations, a CDC-funded study examined vaccination rates among patients who have HIV infection, and the FDA approved a new vaccine.

CDC tracking hepatitis A outbreaks | ACP Gastroenterology Monthly

The CDC received more than 2,500 reports of hepatitis A infections associated with person-to-person transmission from multiple states from January 2017 to April 2018.

Spotlight on autoimmune hepatitis | ACP Gastroenterology Monthly

One study compared the hospitalization rate for autoimmune hepatitis among black, Latino, and Asian/Pacific Islander patients versus a reference rate among white patients, while another study retrospectively analyzed budesonide as a second-line

MKSAP quiz: Complications of hepatitis C-related cirrhosis | ACP Gastroenterology Monthly

This month's quiz asks readers to evaluate a 58-year-old man at a follow-up visit for hepatitis C-related cirrhosis complicated by nonbleeding small esophageal varices and ascites.

8 weeks of ledipasvir/sofosbuvir may be effective for genotype 1 hepatitis C | ACP Gastroenterology Monthly

The therapy should be considered in patients with genotype 1 infection who are treatment-naive, do not have cirrhosis, and have a pretreatment viral load below 6,000,000 IU/mL, a study found.

High HCV cure rate seen with FDA-approved direct-acting antiviral regimens | ACP Gastroenterology Monthly

Six of the direct-acting antiviral (DAA) regimens yielded sustained virologic response rates above 95% in patients who had hepatitis C virus (HCV) genotype 1 without cirrhosis, including those with HIV co-infection.

HCV treatment appeared successful for patients who hadn't responded to previous direct-acting antivirals, industry-funded study finds | ACP Gastroenterology Monthly

The study included two phase 3 trials: POLARIS-1, in which patients with chronic hepatitis C virus (HCV) had previously taken a regimen containing an NS5A inhibitor, and POLARIS-4, in which patients had previously received a direct-acting antiviral

Result Page: Prev   1   2   3   4   5   Next